Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVCRE
āļāļ·āđāļāļāļĢāļīāļĐāļąāļVicore Pharma Holding AB
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 10, 2015
āļāļĩāļāļĩāđāļMousa (Ahmed)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļ- -
āļāļĩāđāļāļĒāļđāđPostbox 14
āđāļĄāļ·āļāļ
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻSweden
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ414 52
āđāļāļĢāļĻāļąāļāļāđ
āđāļ§āđāļāđāļāļāđ
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVCRE
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 10, 2015
āļāļĩāļāļĩāđāļMousa (Ahmed)
Mr. Hans Jeppsson, Ph.D.
Chief Financial Officer
Mr. Hans Schikan, Pharm.D.
Mr. Hans Schikan, Pharm.D.
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Jacob Gunterberg
Independent Director
Ms. Heidi Hunter
Independent Director
Mr. Mikael Nygard
Chief Operating Officer
Mr. Ahmed Mousa
Chief Executive Officer
Dr. Michael Buschle, Ph.D.
Dr. Michael Buschle, Ph.D.
Independent Director
Dr. Elisabeth Bjoerk, M.D., Ph.D.
Dr. Elisabeth Bjoerk, M.D., Ph.D.
Independent Director
Mr. Jimmie Hofman
Chief Business Officer
Ms. Ann Barbier
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Hans Jeppsson, Ph.D.
Chief Financial Officer
Mr. Hans Schikan, Pharm.D.
Mr. Hans Schikan, Pharm.D.
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Jacob Gunterberg
Independent Director
Ms. Heidi Hunter
Independent Director
Mr. Mikael Nygard
Chief Operating Officer
Mr. Ahmed Mousa
Chief Executive Officer